Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
THROMBOGENICS (ENX: THR)
33.85 EUR  -0.15 (-0.43%)
Daily Price  /  Updated: 11:35 AM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
1 Week
1 Month
3 Month
1 Year
3 Year
  
Compare to:
Volume 262,491
Open 34.10
Bid (Size) 33.85 (700)
Ask (Size) 33.85 (350)
Prev. Close 34.00
Today's Range 33.68 - 34.30
52wk Range 17.10 - 47.82
Shares Outstanding 35,860,224
Dividend Yield N/A
Top News
More News
ThromboGenics to Present at the Jefferies 2011 Global Life Sciences Conference in New York
June 07, 2011
from PR Newswire
ThromboGenics and BioInvent Announce the Start of New Study of Novel Antibody Anti-Cancer Agent TB-403 (Anti-PlGF) by Partner Roche
May 16, 2011
from PR Newswire

More News
Read More
ThromboGenics and BioInvent Have Dosed the First Patient in Phase IIb Trial of TB-402 (Anti-Factor VIII) for Venous Thromboembolism (VTE) Prophylaxis
April 27, 2011
from PR Newswire
Positive TB-402(Anti-Factor VIII Antibody) Phase II Data Published in Journal of Thrombosis and Haemostasis
February 11, 2011
from PR Newswire
ThromboGenics Signs Deal With MSD for Long-Term Commercial Supply of Microplasmin
September 30, 2010
from PR Newswire
ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders
September 06, 2010
from PR Newswire
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
September 01, 2010
from PR Newswire
ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina
July 15, 2010
from PR Newswire
ThromboGenics to Present Results of Second Phase III Trial of Microplasmin at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress
July 01, 2010
from PR Newswire
ThromboGenics Presents New Exciting Microplasmin Phase III Data at the World Ophthalmology Congress (WOC) in Berlin
June 07, 2010
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here